Phase II study of a gemcitabine and cisplatin combination regimen in taxane resistant metastatic breast cancer

This publication has 17 references indexed in Scilit:

• What Is the Best Chemotherapy Treatment Option for Anthracycline and Taxane Pretreated Metastatic Breast Cancer?
  Journal of Clinical Oncology, 2005
• Gemcitabine as prolonged infusion and vinorelbine in anthracycline and/or taxane pretreated metastatic breast cancer: a phase II study
  Zeitschrift für Krebsforschung und Klinische Onkologie, 2005
• Randomized Phase III Trial of Pegylated Liposomal Doxorubicin Versus Vinorelbine or Mitomycin C Plus Vinblastine in Women With Taxane-Refractory Advanced Breast Cancer
  Journal of Clinical Oncology, 2004
• Gemcitabine/Cyclophosphamide/5-Fluorouracil/Folinic Acid Triplet Combination in Anthracycline- and Taxane-Refractory Breast Cancer Patients: A Southern Italy Cooperative Oncology Group Phase I/II Study
  Seminars in Oncology, 2001
• Comparison of the antitumor activity of gemcitabine and ara-C in a panel of human breast, colon, lung and pancreatic xenograft models
  Investigational New Drugs, 1996
• Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer.
  Journal of Clinical Oncology, 1996
• Activity of gemcitabine in patients with non-small cell lung cancer: A multicentre, extended phase II study
  European Journal Of Cancer, 1996
• Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: a phase II study.
  Journal of Clinical Oncology, 1994
• A phase II study of cis-diamminedichloroplatinum II for advanced breast cancer two dose schedules
  Zeitschrift für Krebsforschung und Klinische Onkologie, 1984
• Cisplatin in the treatment of metastatic breast carcinoma A prospective randomized trial of two dosage schedules
  American Journal of Clinical Oncology, 1982